Akoya Biosciences Inc (AKYA) Inventory Turnover Ratio, from first quarter 2025 to first quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Akoya Biosciences Inc   (NASDAQ: AKYA)
 

Akoya Biosciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Akoya Biosciences Inc 's inventory turnover ratio, the ratio that measures Akoya Biosciences Inc 's ability to manage its supply chain, sequentially decreased to 1.23 in the first quarter 2025, which does not come as a surprise, as the Akoya Biosciences Inc continue to experience headwinds, which also impact its supply chain. Akoya Biosciences Inc 's average inventory processing period in the Mar 31 2025 quarter, has increased to 297 days, from 268 days, in the Dec 31 2024 quarter.

Within Healthcare sector 304 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2025, to 1549, from total ranking in the fourth quarter 2024 at 1709.

AKYA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Akoya Biosciences Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKYA Inventory Turnover Ratio (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Inventory Growth -0.59 % 36.05 % 34.45 % 53.72 % 58.46 %
Y / Y Cost of Sales Growth -33.33 % -18.92 % -22.22 % -18.18 % -1.28 %
Inventory Turnover Ratio (TTM) 1.23 1.36 1.53 1.75 2.05
AKYA's Total Ranking # 1549 # 1709 # 1629 # 1087 # 1064
Average inventory processing period 296 269 238 209 178
Seq. Inventory Growth -6.04 % -3.53 % 1.68 % 7.86 % 28.59 %
Seq. Cost of Sales Growth -25 % 14.29 % -22.22 % 0 % -8.79 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 19
Healthcare Sector # 305
Overall Market # 1549

Inventory Turnover Ratio Statistics
High Average Low
3.14 2.21 1.24
(Dec 31 2021)   (Mar 31 2025)



AKYA Company Profile >> Back to AKYA Efficiency Comparisons >> Compare AKYA Inventory Turnover Ratio to its Competitors

Financial Statements
Akoya Biosciences Inc 's Inventories $ 23 Millions Visit AKYA's Balance sheet
Akoya Biosciences Inc 's Cost of Revenues TTM $ 30 Millions Visit AKYA's Income Statement
What are AKYA's Sales? Visit AKYA's Sales by Segment

Other Inventory Turnover Ratios
Akoya Biosciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AKYA's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AKYA's Competitors
Inventory Turnover Ratio for AKYA's Suppliers
Inventory Turnover Ratio for AKYA's Customers

You may also want to know
AKYA's Sales Growth Rates AKYA's Pe Price to earnings ratio AKYA's Receivables Turnover Ratio AKYA's Stock Quote
AKYA's Net Income Growth Rates AKYA's Ps Price to Sales ratio AKYA's Sales per Employee AKYA's Asset Turnover Ratio
AKYA's Net Margin AKYA's Pb Price to Book ratio AKYA's Financial Strength Ratios AKYA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2025 Inventories at quarter ending Mar 31 2025
Rigel Pharmaceuticals Inc  3.58 $ 21.031  Millions$ 6  Millions
Dih Holding Us Inc   3.57 $ 30.000  Millions$ 8  Millions
Biofrontera Inc   3.57 $ 21.076  Millions$ 6  Millions
Cadre Holdings inc   3.54 $ 326.456  Millions$ 92  Millions
Zeo Scientifix Inc   3.53 $ 0.848  Millions$ 0  Millions
Myomo Inc   3.51 $ 11.000  Millions$ 3  Millions
Cannapharmarx Inc   3.49 $ 3.851  Millions$ 1  Millions
Elutia Inc   3.48 $ 13.000  Millions$ 4  Millions
Gilead Sciences Inc   3.39 $ 6,239.000  Millions$ 1,841  Millions
Prestige Consumer Healthcare Inc   3.38 $ 503.000  Millions$ 149  Millions
Exelixis Inc   3.34 $ 74.132  Millions$ 22  Millions
Aditxt Inc   3.33 $ 0.562  Millions$ 0  Millions
Baxter International Inc   3.27 $ 7,605.000  Millions$ 2,326  Millions
Inmed Pharmaceuticals Inc  3.23 $ 3.534  Millions$ 1  Millions
Ardelyx inc   3.18 $ 55.731  Millions$ 18  Millions
Sonoma Pharmaceuticals Inc   3.17 $ 8.823  Millions$ 3  Millions
Agilent Technologies inc   3.16 $ 3,092.000  Millions$ 978  Millions
Becton Dickinson And Company  3.16 $ 11,581.000  Millions$ 3,666  Millions
Tandem Diabetes Care Inc   3.10 $ 469.000  Millions$ 151  Millions
Maravai Lifesciences Holdings Inc   3.04 $ 151.666  Millions$ 50  Millions
Mettler toledo International Inc   3.02 $ 1,088.733  Millions$ 361  Millions
Elite Pharmaceuticals Inc   3.01 $ 43.000  Millions$ 14  Millions
Dexcom Inc   3.01 $ 1,682.000  Millions$ 559  Millions
Amneal Pharmaceuticals Inc   3.00 $ 1,790.478  Millions$ 596  Millions
Msa Safety Inc  3.00 $ 957.000  Millions$ 319  Millions
Dentsply Sirona Inc   3.00 $ 1,801.000  Millions$ 601  Millions
International Stem Cell Corporation  2.97 $ 3.869  Millions$ 1  Millions
Akebia Therapeutics Inc   2.95 $ 59.197  Millions$ 20  Millions
Nexgel Inc   2.94 $ 5.011  Millions$ 2  Millions
Brightspring Health Services Inc   2.94 $ 1,488.101  Millions$ 507  Millions

Date modified: 2026-09-08T15:11:30+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.